-
Primerjava stroškov in učinkovitosti inhaliranega flutikazonpropionata in budezionida za zdravljenje astme pri odraslih in otrocih = The cost effectiveness of inhalited fluticasone propionate and budesonide in the treatment of asthma in adults and childrenLloyd, Adam C. ; Šorli, Jurij, 1942- ; Cencelj, SimonaBackground. This study compared the costs and effectiveness of fluticasone propionate (FP) and budesonide (BUD) in the treatment af asthma in Slovenia. The population was mixture of adults and ... children with asthma of varying severity included in a recently published meta-analysis. Results. Patients treated with FP were, on average, successfully controlled for 41.7% of treatedweeks compared with 34.1% in the BUD group (p<0.001). The FP group alsoshowed significantly greater improvements symptom-free days, symptom-free 24 hour periods and episode free days. The overall mean weekly cost per patients was 3077 SIT for patieents treated with BUD and 1916 SIT for patientstreated with FP. The purcase price of FP was similar to that of BUD (1524 SIT vs. 1462 SIT per week), but the costs of health care contacts were lower in the FP group (56 SIT vs. 1275 SIT per week). When all asthma-relatedhealth care costs were taken into account, the FP group had lower average costs than the BUD group. The total expenditure per week of successful treatment was 4594 for patients treated with FP and 9025 SIT for patients treated with BUD. FP was more cost-effective than BUD for all effectiveness endpoints assessed. Conclusion. FP would reduce costs at least at the same effectiveness compared to BUD.Vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 68, št. 12, dec. 1999, str. 737-741)Vrsta gradiva - članek, sestavni delLeto - 1999Jezik - slovenskiCOBISS.SI-ID - 11072217
Avtor
Lloyd, Adam C. |
Šorli, Jurij, 1942- |
Cencelj, Simona
Teme
Asthma |
Drug therapy |
Adrenal cortex hormones |
Drug costs |
Cost-benefit analysis |
Adult |
Child |
Meta-analysis |
astma |
zdravljenje |
stroški
![loading ... loading ...](themes/default/img/ajax-loading.gif)
vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 68, št. 12, dec. 1999, str. 737-741)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Šorli, Jurij, 1942- | 09808 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi